A detailed history of Ogorek Anthony Joseph transactions in Organon & Co. stock. As of the latest transaction made, Ogorek Anthony Joseph holds 108 shares of OGN stock, worth $813. This represents 0.0% of its overall portfolio holdings.

Number of Shares
108
Previous 43 151.16%
Holding current value
$813
Previous $0 Infinity%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 04, 2025

BUY
$8.4 - $10.85 $546 - $705
65 Added 151.16%
108 $1,000
Q2 2025

Aug 08, 2025

BUY
$8.04 - $14.72 $345 - $632
43 New
43 $0
Q1 2022

Apr 26, 2022

SELL
$30.45 - $39.36 $152 - $196
-5 Closed
0 $0
Q2 2021

Jul 14, 2021

BUY
$28.45 - $38.0 $142 - $190
5 New
5 $0

Others Institutions Holding OGN

About Organon & Co.


  • Ticker OGN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 254,330,000
  • Market Cap $1.92B
  • Description
  • Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...
More about OGN
Track This Portfolio

Track Ogorek Anthony Joseph Portfolio

Follow Ogorek Anthony Joseph and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ogorek Anthony Joseph , based on Form 13F filings with the SEC.

News

Stay updated on Ogorek Anthony Joseph with notifications on news.